Forces influencing generic drug development in the United States: a narrative review

Journal of Pharmaceutical Policy and Practice

Chia-Ying Lee¹  Jodi B. Segal¹  Xiaohan Chen¹  Robert J. Romanelli¹ 

[1] 1Johns Hopkins University Bloomberg School of Public Health, Center for Drug Safety and Effectiveness, 624 N. Broadway, Room 644, Baltimore, MD 21205 USA

关键词: Generic drug;    Incentives;    U.S. Food and Drug Administration;   

DOI  :  10.1186/s40545-016-0079-1

学科分类：药理学

来源: BioMed Central

【 摘 要 】

Background

The United States (U.S.) Food and Drug Administration, as protectors of public health, encourages generic drug development and use so that patients can access affordable medications. The FDA, however, has limited mechanisms to encourage generic drug manufacturing.

【 授权许可】

Unknown